Sort
82,697 grants matching “vaccine development”
Improving clinical decision support reliability using anomaly detection methods
$691,638Adam T Wright · Brigham And Women'S Hospital · R01 · FY2014 · LM
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
$691,619Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$691,610William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$691,592Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$691,567James L. Sorensen · University Of California, San Francisco · UG1 · FY2019 · DA
Host and parasite factors influencing P. vivax RBC invasion and asexual development
$691,533David Serre · University Of Maryland Baltimore · R01 · FY2024 · AI
Development of small near-infrared laser system capable of improving immune responses to vaccines (laser-based adjuvant)
$691,508David Bean · Veralase, Llc · R42 · FY2017 · AI
Proyecto Tariki: Implementation Science for Community-Mobilized Risk Reduction of Dengue
$691,508Valerie Andrea Paz-Soldan · Tulane University Of Louisiana · R01 · FY2024 · AI
Exploring the coevolutionary potential of chikungunya virus and its Aedes mosquito vectors
$691,501Elizabeth Ann McGraw · Pennsylvania State University, The · R01 · FY2023 · AI
Rochester Roybal Center for Social Ties and Aging Research
$691,485Kathi L Heffner · University Of Rochester · P30 · FY2023 · AG
Preclinical studies of PG70 LEAPS peptide vaccines for rheumatoid arthritis
$691,469Daniel Hill Zimmerman · Cel-Sci Corporation · R44 · FY2018 · AR
Human Antibodies and Targeted Vaccines Against SARS-CoV
$691,466Dana-Farber Cancer Institute · U01 · FY2005 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus
$691,456Gregg A Dean · Colorado State University · R01 · FY2020 · AI
DISSEMINATED TUBERCULOSIS IN HIV INFECTION
$691,436Dartmouth College · R01 · FY2000 · AI
Evaluation of Novel PE Malaria Vaccine Candidates
$691,420Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children
$691,420Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Structural characterization of outer membrane proteins from Yersinia pestis
$691,347Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
$691,271Fei Chen · Broad Institute, Inc. · R01 · FY2023 · CA
International Collaborations in Infectious Disease Research (ICIDR) (U01)
$691,145Matthew Lester Boulton · University Of Michigan At Ann Arbor · U01 · FY2014 · AI
PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED
$691,073Robert Rodriguez · University Of California, San Francisco · R01 · FY2022 · AI
Identification of serological markers of protection and risk for dengue vaccines and natural infection
$691,067Derek A Cummings · University Of Florida · R01 · FY2023 · AI
Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats
$690,994Natalie Exner Dean · Emory University · R01 · FY2022 · AI
CAREER: Developing Thermal Gel Electrophoresis to Interrogate Higher Order Biological Structure
$690,948Thomas Linz · Wayne State University · · FY2021 · MPS
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal
$690,909Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2024 · CA
Community Engagement Core
$690,902Bibiana Marie Mancera · University Of Texas El Paso · U54 · FY2021 · MD